At Max Group, we don't just imagine the future of health; we build it. We are a dynamic and unified ecosystem that combines the deepest knowledge, cutting-edge technology, and an unwavering passion for human well-being. Our purpose is clear: to catalyze systemic transformation in the healthcare sector, addressing it from a truly global and holistic perspective.
We convert advanced research and clinical experience into practical and effective solutions.
We develop innovative digital tools and platforms that optimize healthcare and management.
We ensure equitable access to quality patient-centered healthcare.
We address health challenges without borders, with scalable and replicable solutions.
Let's build a fairer, more equitable, and sustainable future together.
We stay at the forefront, anticipating future needs and adapting to change.
We unite brilliant talents and strategic resources to build a future where health is more accessible, efficient, and empathetic for everyone. At Max Group, every step we take is driven by the conviction that we can and must make a tangible difference in people's lives.
We are a new global alliance that transforms the pharmaceutical and health technology industry globally, led by Weber, an innovation driver, along with its strategic allies. Together, we offer comprehensive solutions that enhance access and growth in the sector, combining expertise, technology, and a global vision to drive change and generate value.
Strategic healthcare consulting firm specializing in innovation, market access, and value-based contracting.
Acts as the main consultancy, combining over 20 years of experience in the healthcare sector with an innovative focus on health economics, pharmacoeconomic evaluation, and market access.
Comprehensive services in market access, strategic advice, and development of value-added programs for innovative health products.
We aim to become the leading reference in health consulting, with presence in Europe, LATAM, and the USA, focusing our efforts on the evaluation of health technologies and the quantification of their social and economic value. Thus, we accelerate their market access and contribute to improving the quality of life of patients and the well-being of the societies in which we operate.